Open Access

Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity

  • Authors:
    • Meropi Toumba
    • Pavlos Fanis
    • Dimitrios Vlachakis
    • Vassos Neocleous
    • Leonidas A. Phylactou
    • Nicos Skordis
    • Christos S. Mantzoros
    • Maria Pantelidou
  • View Affiliations

  • Published online on: November 24, 2021     https://doi.org/10.3892/ijmm.2021.5065
  • Article Number: 10
  • Copyright: © Toumba et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Severe early‑onset obesity is mainly attributed to single gene variations of the hypothalamic leptin‑melanocortin system, which is critical for controlling the balance between appetite and energy expenditure. Adenylate cyclase 3 (ADCY3), a transmembrane enzyme localized in primary neuronal cilia, is a key genetic candidate, which appears to have an essential role in regulating body weight. The present study aimed to identify ADCY3 genetic variants in severely obese young patients of Greek‑Cypriot origin by genomic sequencing. Apart from previously reported variants, the novel and probably pathogenic variant c.349T>A, causing a p.Leu117Met substitution within one of the two pseudo‑symmetric halves of the transmembrane part of the protein, was reported. Molecular modelling analysis used to delineate bonding interactions within the mutated protein structure strongly suggested a change in interactive forces and energy levels affecting the pseudo‑twofold symmetry of the transmembrane domain of the protein and probably its catalytic function. These results support the involvement of ADCY3 in the pathology of the disease and point towards the requirement of defining protein function and evaluating the clinical significance of the detected variants.

Related Articles

Journal Cover

January-2022
Volume 49 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Toumba M, Fanis P, Vlachakis D, Neocleous V, Phylactou LA, Skordis N, Mantzoros CS and Pantelidou M: Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity. Int J Mol Med 49: 10, 2022
APA
Toumba, M., Fanis, P., Vlachakis, D., Neocleous, V., Phylactou, L.A., Skordis, N. ... Pantelidou, M. (2022). Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity. International Journal of Molecular Medicine, 49, 10. https://doi.org/10.3892/ijmm.2021.5065
MLA
Toumba, M., Fanis, P., Vlachakis, D., Neocleous, V., Phylactou, L. A., Skordis, N., Mantzoros, C. S., Pantelidou, M."Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity". International Journal of Molecular Medicine 49.1 (2022): 10.
Chicago
Toumba, M., Fanis, P., Vlachakis, D., Neocleous, V., Phylactou, L. A., Skordis, N., Mantzoros, C. S., Pantelidou, M."Molecular modelling of novel ADCY3 variant predicts a molecular target for tackling obesity". International Journal of Molecular Medicine 49, no. 1 (2022): 10. https://doi.org/10.3892/ijmm.2021.5065